カテゴリ： MarketLine, UAE, 企業調査

Takaful Emarat – Insurnace (P.S.C)：企業の戦略・SWOT・財務情報

◆英語タイトル：Takaful Emarat - Insurnace (P.S.C) - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C11895
◆発行会社（調査会社）：MarketLine
◆発行日：2018年11月
◆ページ数：32
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：UAE
◆産業分野：サービス
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Takaful Emarat – Insurnace (P.S.C) – Strategy, SWOT and Corporate Finance Report
Summary

Takaful Emarat – Insurnace (P.S.C) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Takaful Emarat – Insurnace (P.S.C) (Takaful Emarat) is an Islamic insurance company. The company provides a range of takaful insurance products. Its portfolio of products include whole-life plan, wealth plan, education plan, Al Moyassara plan, level term plan, takaful growth plan and decreasing term plan. Takaful Emarat also offers personal accident plan, travel insurance plan, group life plan, health plan, and group credit plan. The company offers health insurance products, which comprise individual and group health plans. The company caters to individuals and corporate clients. It has offices in Dubai, Abu Dhabi and Sharjah. Takaful Emarat is headquartered in Dubai, the UAE.

The company reported gross contributions written of AED568.2 million during fiscal year ended December 2016 (FY2016), an increase of 41% over FY2015. Its net earned contributions was AED374.9 million in FY2016, an increase of 17.2% over FY2015.

Scope

- Detailed information on Takaful Emarat – Insurnace (P.S.C) required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Takaful Emarat – Insurnace (P.S.C) in the form of a SWOT analysis
- An in-depth view of the business model of Takaful Emarat – Insurnace (P.S.C) including a breakdown and examination of key business segments
- Intelligence on Takaful Emarat – Insurnace (P.S.C)’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Takaful Emarat – Insurnace (P.S.C), such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Takaful Emarat – Insurnace (P.S.C) and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Takaful Emarat – Insurnace (P.S.C) as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Takaful Emarat – Insurnace (P.S.C)’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Takaful Emarat – Insurnace (P.S.C): Company Overview 9
Takaful Emarat – Insurnace (P.S.C): Overview and Key Facts 9
Takaful Emarat – Insurnace (P.S.C): Overview 9
Takaful Emarat – Insurnace (P.S.C): Key Facts 9
Takaful Emarat – Insurnace (P.S.C): Key Employees 11
Takaful Emarat – Insurnace (P.S.C): Major Products and Services 12
Takaful Emarat – Insurnace (P.S.C): Company History 13
Takaful Emarat – Insurnace (P.S.C): Management Statement 14
Takaful Emarat – Insurnace (P.S.C): Locations and Subsidiaries 16
Takaful Emarat – Insurnace (P.S.C): Key Competitors 17
Takaful Emarat – Insurnace (P.S.C): Company Analysis 18
Takaful Emarat – Insurnace (P.S.C): Business Description 18
Takaful Emarat – Insurnace (P.S.C): SWOT Analysis 19
Takaful Emarat – Insurnace (P.S.C): SWOT Overview 19
Takaful Emarat – Insurnace (P.S.C): Strengths 19
Takaful Emarat – Insurnace (P.S.C): Weaknesses 20
Takaful Emarat – Insurnace (P.S.C): Opportunities 20
Takaful Emarat – Insurnace (P.S.C): Threats 20
Takaful Emarat – Insurnace (P.S.C): Corporate Financial Deals Activity 22
Takaful Emarat – Insurnace (P.S.C): Financial Deals Overview 22
Takaful Emarat – Insurnace (P.S.C): Targets and Partners 24
Takaful Emarat – Insurnace (P.S.C): Top Deals 2014 – 2018YTD* 25
Takaful Emarat – Insurnace (P.S.C): Advisors 26
Takaful Emarat – Insurnace (P.S.C): Top Legal Advisors 26
Takaful Emarat – Insurnace (P.S.C): Mergers and Acquisitions 27
Takaful Emarat – Insurnace (P.S.C): Recent Developments 28
Takaful Emarat – Insurnace (P.S.C): News and Events Summary 28
Takaful Emarat – Insurnace (P.S.C): Corporate Governance 28
Takaful Emarat – Insurnace (P.S.C): Strategy and Operations 28
Appendix 30
Contact Us 30
Methodology 30
About MarketLine 31

List of Tables
Table 1: Takaful Emarat - Insurnace (P.S.C): Key Facts
Table 2: Takaful Emarat - Insurnace (P.S.C): Key Employees
Table 3: Takaful Emarat - Insurnace (P.S.C): Company History
Table 4: Takaful Emarat - Insurnace (P.S.C): Locations and Subsidiaries
Table 5: Takaful Emarat - Insurnace (P.S.C): Key Competitors
Table 6: Takaful Emarat - Insurnace (P.S.C): Deal Activity by Deal Type - Volume (TTM*)
Table 7: Takaful Emarat - Insurnace (P.S.C): M&A Activity by Geography (TTM*)
Table 8: Takaful Emarat - Insurnace (P.S.C): Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 9: Takaful Emarat - Insurnace (P.S.C): Targets and Partners
Table 10: Takaful Emarat - Insurnace (P.S.C): Top Deals 2014 - 2018YTD*
Table 11: Takaful Emarat - Insurnace (P.S.C): Legal Advisor Ranking by Value (US$m)
Table 12: Takaful Emarat - Insurnace (P.S.C): M&A Volume and Value Trend (2014 - YTD*2018)
Table 13: Takaful Emarat - Insurnace (P.S.C): M&A Activity by Geography (2014 - YTD*2018)
Table 14: Takaful Emarat - Insurnace (P.S.C): News and Events Summary
Table 15: Takaful Emarat - Insurnace (P.S.C): Corporate Governance
Table 16: Takaful Emarat - Insurnace (P.S.C): Strategy and Operations

List of Figures
Figure 1: Takaful Emarat - Insurnace (P.S.C): Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Takaful Emarat - Insurnace (P.S.C): M&A Activity by Geography (TTM*)
Figure 3: Takaful Emarat - Insurnace (P.S.C): Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Takaful Emarat - Insurnace (P.S.C): M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: Takaful Emarat - Insurnace (P.S.C): M&A Activity by Geography (2014 - YTD*2018)

★海外企業調査レポート[Takaful Emarat – Insurnace (P.S.C)：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Petroleo Brasileiro S.A. (Petrobras)：戦略・SWOT・企業財務分析
    Petroleo Brasileiro S.A. (Petrobras) - Strategy, SWOT and Corporate Finance Report Summary Petroleo Brasileiro S.A. (Petrobras) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Redrow Plc：企業の戦略・SWOT・財務情報
    Redrow Plc - Strategy, SWOT and Corporate Finance Report Summary Redrow Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Philips Healthcare-医療機器分野：企業M&A・提携分析
    Summary Philips Healthcare, formerly Philips Medical Systems, undertakes the manufacture and distribution of diagnostic imaging systems, healthcare information technology solutions, patient monitoring and cardiac devices. Philips Healthcare is a division of Royal Philips Electronics of the Netherlan …
  • Microchip Technology Incorporated：企業の戦略・SWOT・財務情報
    Microchip Technology Incorporated - Strategy, SWOT and Corporate Finance Report Summary Microchip Technology Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • BioCryst Pharmaceuticals Inc (BCRX)：企業の財務・戦略的SWOT分析
    BioCryst Pharmaceuticals Inc (BCRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • The Dow Chemical Company：企業の戦略・SWOT・財務情報
    The Dow Chemical Company - Strategy, SWOT and Corporate Finance Report Summary The Dow Chemical Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Brodrene Hartmann AS：戦略・SWOT・企業財務分析
    Brodrene Hartmann AS - Strategy, SWOT and Corporate Finance Report Summary Brodrene Hartmann AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Aduro BioTech Inc (ADRO)：企業の財務・戦略的SWOT分析
    Summary Aduro BioTech Inc (Aduro BioTech) is a clinical-stage immunotherapy company that discovers, develops and commercializes therapies for the treatment of cancer. The company develops product candidates using proprietary technology platforms such as live, attenuated, double-deleted listeria, sti …
  • Cytox Ltd-医療機器分野：企業M&A・提携分析
    Summary Cytox Ltd (Cytox) is a diagnostic and prognostic service provider that develops services for neurodegenerative disorders. The company’s blood tests are used to predict, which patients with MCI will develop Alzheimer's disease. Its biomarkers are based on the cell cycle hypothesis of Alzheime …
  • Gamida Cell Ltd：企業のM&A・事業提携・投資動向
    Gamida Cell Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Gamida Cell Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Didion Milling Inc.：企業の戦略・SWOT・財務情報
    Didion Milling Inc. - Strategy, SWOT and Corporate Finance Report Summary Didion Milling Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Nedbank Group Ltd (NED)：企業の財務・戦略的SWOT分析
    Nedbank Group Ltd (NED) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Teck Resources Ltd：戦略・SWOT・企業財務分析
    Teck Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Teck Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Sunstone Hotel Investors Inc：戦略・SWOT・企業財務分析
    Sunstone Hotel Investors Inc - Strategy, SWOT and Corporate Finance Report Summary Sunstone Hotel Investors Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Gabather AB：製薬・医療：M&Aディール及び事業提携情報
    Summary Gabather AB (Gabather) is a developer of new drug candidates for the treatment of central nervous system diseases. The company spans its expertise in the development of anti-psychotics, anti-depressants and anxiolytics, analgesics, and cognition-enhancing treatments. It offers drug candidate …
  • Biocept Inc (BIOC)：製薬・医療：M&Aディール及び事業提携情報
    Summary Biocept Inc (Biocept) is a molecular diagnostics company. The company develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA assays utilizing a standard blood sample. It offers assays for solid tumor indications, such as breast cancer, non-small cell l …
  • AmerisourceBergen Corporation：企業の戦略・SWOT・財務情報
    AmerisourceBergen Corporation - Strategy, SWOT and Corporate Finance Report Summary AmerisourceBergen Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Sartorius Stedim Biotech SA (DIM)：企業の財務・戦略的SWOT分析
    Sartorius Stedim Biotech SA (DIM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Avery Dennison Corporation (AVY)：企業の財務・戦略的SWOT分析
    Avery Dennison Corporation (AVY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Care Group：企業の製品パイプライン分析2018
    Summary Care Group India (Care Group) is a manufacturer and supplier of intraocular lens (IOLs) and ophthalmic surgical products. Its product portfolio includes cataract intraocular lens (IOLs) including hydrophilic, hydrophobic, polymethyl methacrylate (PMMA) models and implantable phakic contact l …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆